AGAPE ATP CORPORATION Operating Cash Flow
AGAPE ATP CORPORATION (ATPC) reported Operating Cash Flow of -$505.09 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$110.32K.
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$394.77K.
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$208.35K.
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$256.74K.
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was -$2.41M.
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was -$2.73M.
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was -$2.00M.
- AGAPE ATP CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was -$811.68K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$110.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$505.09K 10-Q · filed 2026-08-14 | -$713.44K derived: sum of 3 quarters · filed 2026-08-14 | -$970.18K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$394.77K 10-Q · filed 2026-05-15 | -$603.12K derived: sum of 2 quarters · filed 2026-05-15 | -$859.86K derived: sum of 3 quarters · filed 2026-05-15 | -$1.35M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$208.35K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$465.09K derived: sum of 2 quarters · filed 2026-04-13 | -$959.55K derived: sum of 3 quarters · filed 2026-08-14 | -$2.41M 10-K · filed 2026-04-13 | |
| 2025-09-30 | -$256.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$751.20K derived: sum of 2 quarters · filed 2026-08-14 | -$2.21M 10-Q · filed 2025-11-13 | -$2.85M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$494.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.95M 10-Q · filed 2026-08-14 | -$2.59M derived: sum of 3 quarters · filed 2026-08-14 | -$3.02M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$1.45M 10-Q · filed 2026-05-15 | -$2.10M derived: sum of 2 quarters · filed 2026-05-15 | -$2.52M derived: sum of 3 quarters · filed 2026-05-15 | -$2.94M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$645.34K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | -$1.07M derived: sum of 2 quarters · filed 2026-04-13 | -$1.48M derived: sum of 3 quarters · filed 2026-04-13 | -$2.73M 10-K · filed 2026-04-13 | |
| 2024-09-30 | -$424.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$837.42K derived: sum of 2 quarters · filed 2025-11-13 | -$2.08M 10-Q · filed 2025-11-13 | -$3.09M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | -$412.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$1.66M 10-Q · filed 2025-08-13 | -$2.66M derived: sum of 3 quarters · filed 2025-08-13 | -$2.92M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$1.24M 10-Q · filed 2025-05-15 | -$2.25M derived: sum of 2 quarters · filed 2025-05-15 | -$2.50M derived: sum of 3 quarters · filed 2025-05-15 | -$2.97M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.26M derived: sum of 2 quarters · filed 2025-03-31 | -$1.73M derived: sum of 3 quarters · filed 2025-03-31 | -$2.00M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$253.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$723.15K derived: sum of 2 quarters · filed 2024-11-14 | -$995.71K 10-Q · filed 2024-11-14 | -$1.07M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$469.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$742.17K 10-Q · filed 2024-08-14 | -$816.40K derived: sum of 3 quarters · filed 2024-08-14 | -$1.06M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$272.56K 10-Q · filed 2024-05-14 | -$346.78K derived: sum of 2 quarters · filed 2024-05-14 | -$588.51K derived: sum of 3 quarters · filed 2024-05-14 | -$933.12K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$74.23K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$315.96K derived: sum of 2 quarters · filed 2024-04-01 | -$660.56K derived: sum of 3 quarters · filed 2024-04-01 | -$811.68K 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$241.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$586.33K derived: sum of 2 quarters · filed 2023-11-14 | -$737.46K 10-Q · filed 2023-11-14 | -$1.04M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$344.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$495.73K 10-Q · filed 2023-08-14 | -$493.33K 10-Q · filed 2022-08-11 | -$800.13K derived: sum of 3 quarters · filed 2023-08-14 | -$1.21M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$151.12K 10-Q · filed 2023-05-15 | -$455.52K derived: sum of 2 quarters · filed 2023-05-15 | -$862.22K derived: sum of 3 quarters · filed 2023-05-15 | -$867.67K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$304.40K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$711.09K derived: sum of 2 quarters · filed 2023-03-31 | -$716.54K derived: sum of 3 quarters · filed 2023-03-31 | -$845.84K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$406.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$412.14K derived: sum of 2 quarters · filed 2022-11-14 | -$541.44K 10-Q · filed 2022-11-14 | -$355.72K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$5.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$134.75K 10-Q · filed 2022-08-11 | $50.97K derived: sum of 3 quarters · filed 2022-08-11 | $87.97K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$129.30K 10-Q · filed 2022-05-13 | $56.42K derived: sum of 2 quarters · filed 2022-07-05 | $93.42K derived: sum of 3 quarters · filed 2022-07-05 | -$456.82K derived: sum of 4 quarters · filed 2022-07-05 | |
| 2020-12-31 | $185.72K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $222.71K derived: sum of 2 quarters · filed 2022-07-05 | -$327.52K derived: sum of 3 quarters · filed 2022-07-05 | -$557.95K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | $36.99K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | -$513.24K derived: sum of 2 quarters · filed 2022-07-05 | -$743.67K 10-Q/A · filed 2022-07-05 | -$756.42K derived: sum of 4 quarters · filed 2022-07-05 | |
| 2020-06-30 | -$550.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$780.66K 10-Q · filed 2021-08-13 | -$793.41K derived: sum of 3 quarters · filed 2021-08-13 | -$894.61K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | -$230.43K 10-Q · filed 2021-05-17 | -$243.18K derived: sum of 2 quarters · filed 2021-05-17 | -$344.38K derived: sum of 3 quarters · filed 2021-05-17 | -$576.53K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$12.75K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-31 | -$113.94K 10-K · filed 2021-03-31 | -$346.10K derived: sum of 3 quarters · filed 2021-03-31 | -$704.42K 10-K · filed 2021-03-31 | |
| 2019-09-30 | -$101.20K 10-Q · filed 2019-11-12 | -$333.35K derived: sum of 2 quarters · filed 2020-08-13 | -$691.67K 10-Q · filed 2020-11-16 | -$1.08M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-06-30 | -$232.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$590.47K 10-Q · filed 2020-08-13 | -$974.07K derived: sum of 3 quarters · filed 2020-08-13 | -$667.06K 10-K · filed 2020-03-27 | |
| 2019-03-31 | -$358.32K 10-Q · filed 2020-05-14 | -$741.92K derived: sum of 2 quarters · filed 2020-05-14 | -$435.66K 10-Q · filed 2019-05-13 | -$521.96K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$383.60K derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-27 | -$76.59K 10-K · filed 2020-03-27 | -$77.34K 10-Q · filed 2019-02-15 | -$163.63K derived: sum of 3 quarters · filed 2020-03-27 | $468.26K derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-09-30 | $307.00K 10-Q · filed 2019-11-12 | $219.96K derived: sum of 2 quarters · filed 2020-03-27 | $851.86K derived: sum of 3 quarters · filed 2020-03-27 | $114.05K derived: sum of 4 quarters · filed 2020-03-27 | |
| 2018-06-30 | -$87.04K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $544.86K derived: sum of 2 quarters · filed 2020-03-27 | -$192.95K derived: sum of 3 quarters · filed 2020-03-27 | -$347.98K 10-K · filed 2020-03-27 | |
| 2018-03-31 | $631.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-13 | -$105.91K derived: sum of 2 quarters · filed 2019-05-13 | -$260.93K 10-Q · filed 2019-05-13 | ||
| 2017-12-31 | -$737.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-15 | -$892.83K 10-Q · filed 2019-02-15 | -$892.83K 10-Q · filed 2018-02-13 | ||
| 2017-09-30 | -$155.03K 10-Q · filed 2017-11-13 | ||||
| 2017-06-30 | -$100.26K 10-K · filed 2018-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |